Fable 5 Returns

US export controls on Fable 5 and Mythos 5 have lifted. Anthropic details the Amazon-reported bypass, its fix, and a new Glasswing-backed framework for scoring AI jailbreak severity

Discover more

Lies, Damned Lies, and Apparently My Audience Knows Best

Nearly half of everything you've watched on this channel in recent months has clustered around five conversations, and all five keep circling the same uncomfortable subject.

Discover more

OpenAI and Broadcom unveil custom inference chip "Jalapeño"

Nine month design cycle, deployment from end 2026, gigawatt scale rollout planned with Microsoft.

Discover more

Mistral beefs up enterprise controls for its AI connectors

with granular admin controls, scoped API keys, multi-account support and a new debugging tool for MCP connections.

Discover more

xAI launches autonomous task mode for Grok Build

Agents plan, checklist and complete coding jobs unsupervised, with status, pause, resume and clear commands giving developers oversight throughout.

Discover more

OpenAI Launches Daybreak to Tackle Cybersecurity's "Patching Bottleneck"

OpenAI's Daybreak shifts cyber AI focus from finding flaws to fixing them, pairing an upgraded GPT-5.5-Cyber and Codex Security with a new vendor partner programme and an open-source patching drive.

Discover more

137 Trillion Emails and Counting: Why I'm Cutting Ours Down

The road to hell is paved with good intentions, and most of them arrive as newsletters. On unsubscribe culture, marketing bullshit, and why your voice is more welcome here than your inbox space.

Discover more

Mad With Power: Anthropic, OpenAI and Elon's Very Different Weeks

A government order pulls Fable 5 offline, OpenAI talks up its own safety testing, and Musk buys Cursor for $60bn. Plus: the ChatGPT story that makes the rest look small.

Discover more
01
04
Latest posts
Meta's Open-Source AI Models Drive Breakthrough Healthcare Advancements in Oncology and Clinical Trials
Meta's Open-Source AI Models Drive Breakthrough Healthcare Advancements in Oncology and Clinical Trials

Meta's open-source AI models enable 26.8% higher cancer treatment prediction accuracy and reduce clinical trial matching from hundreds of days to just one day.

by AI-360
xAI Unveils Grok 3 With Advanced Reasoning Capabilities, Setting New Enterprise AI Benchmark
xAI Unveils Grok 3 With Advanced Reasoning Capabilities, Setting New Enterprise AI Benchmark

Grok 3's 'Think' capability exposes its full reasoning process, allowing users to inspect how it explores alternatives and corrects errors, addressing AI explainability demands.

by AI-360
UK-Australia Partnership Bolsters Defence AI Capabilities Through Cross-Border Research Alliance
UK-Australia Partnership Bolsters Defence AI Capabilities Through Cross-Border Research Alliance

The partnership establishes three research streams: defense AI applications, emerging AI threats to security, and risk frameworks that balance innovation with responsibility.

by AI-360
OpenAI-Guardian Partnership Expands AI Content Access for 300M Weekly Users
OpenAI-Guardian Partnership Expands AI Content Access for 300M Weekly Users

Beyond content licencing, The Guardian adopts ChatGPT Enterprise across operations to develop new AI-powered products for readers while maintaining attribution and IP rights.

by Stewart Tinson
Google Pivots Enterprise AI Strategy to Expand Defence Sector Opportunities
Google Pivots Enterprise AI Strategy to Expand Defence Sector Opportunities

Google removed long-standing ethical constraints against weaponised AI applications, allowing expansion into defence contracting for military AI development.

by AI-360
Law Firm Implements Strategic AI Governance After Finding 32,000+ Unauthorised ChatGPT Uses
Law Firm Implements Strategic AI Governance After Finding 32,000+ Unauthorised ChatGPT Uses

The firm detected more than 32,000 ChatGPT interactions in just one week—many unauthorised under the firm's AI policies.

by AI-360
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Great! You've successfully signed up.
Great! You've successfully signed up.
Welcome back! You've successfully signed in.
Success! You now have access to additional content.